<DOC>
	<DOCNO>NCT01252888</DOCNO>
	<brief_summary>The purpose study assess efficacy safety two iStents reduction intraocular pressure associate primary open-angle glaucoma .</brief_summary>
	<brief_title>Prospective Evaluation Open-angle Glaucoma Subjects Two Topical Hypotensive Medication Treated With Two iStents</brief_title>
	<detailed_description>This study evaluate safety efficacy two iStents implanted primary open-angle glaucoma subject .</detailed_description>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Glaucoma , Open-Angle</mesh_term>
	<mesh_term>Antihypertensive Agents</mesh_term>
	<criteria>Diagnosed primary openangle glaucoma ( POAG ) Subjects two topical hypotensive medication Traumatic , uveitic , neovascular , angle closure glaucoma Fellow eye already enrol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Open angle</keyword>
	<keyword>Glaucoma</keyword>
	<keyword>Surgery</keyword>
	<keyword>Glaucoma Open-Angle</keyword>
	<keyword>Ocular Hypertension</keyword>
	<keyword>Eye Diseases</keyword>
</DOC>